Compare IMAX & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMAX | LMAT |
|---|---|---|
| Founded | 1967 | 1983 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | 1997 | 2006 |
| Metric | IMAX | LMAT |
|---|---|---|
| Price | $38.60 | $101.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | $44.50 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 1.0M | 347.2K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | ★ 31.25 | 30.57 |
| EPS | 0.07 | ★ 0.68 |
| Revenue | ★ $410,212,000.00 | $249,602,000.00 |
| Revenue This Year | $9.79 | $14.21 |
| Revenue Next Year | $7.51 | $8.88 |
| P/E Ratio | $559.00 | ★ $149.35 |
| Revenue Growth | ★ 16.47 | 13.53 |
| 52 Week Low | $24.20 | $79.01 |
| 52 Week High | $45.52 | $118.01 |
| Indicator | IMAX | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 44.02 | 56.07 |
| Support Level | $38.58 | $82.47 |
| Resistance Level | $40.56 | $114.98 |
| Average True Range (ATR) | 1.46 | 3.53 |
| MACD | -0.16 | 0.27 |
| Stochastic Oscillator | 36.02 | 66.88 |
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.